uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Good adherence to adjuvant endocrine therapy in early breast cancer: a population-based study based on the Swedish prescribed Drug Register
Ryhov Cty Hosp, Dept Oncol, Jonkoping, Sweden;Lund Univ, Dept Clin Sci Lund, Div Oncol & Pathol, Bldg 406,Scheelevagen 8, SE-22363 Lund, Sweden.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Experimental and Clinical Oncology.
Acad Hlth & Care, Futurum, Reg Jonkoping Cty, Jonkoping, Sweden;Jonkoping Univ, Sch Hlth & Welf, Dept Social Work, Jonkoping, Sweden.
Ryhov Cty Hosp, Dept Oncol, Jonkoping, Sweden;Acad Hlth & Care, Futurum, Reg Jonkoping Cty, Jonkoping, Sweden.
2018 (English)In: Acta Oncologica, ISSN 0284-186X, E-ISSN 1651-226X, Vol. 57, no 7, p. 935-940Article in journal (Refereed) Published
Abstract [en]

Introduction: Adjuvant endocrine therapy improves recurrence-free and overall survival in primary breast cancer. However, not all patients complete their planned treatment, mostly because of side-effects. The aim of this study was to examine the adherence to adjuvant endocrine therapy in a cohort of primary breast cancer patients in Region Jonkoping County, Sweden, after 3 and 5 years.

Material and methods: The Swedish Breast Cancer Register was used to identify patients diagnosed with hormone receptor positive breast cancer in Region Jonkoping County between 2009 and 2012. Adherence was evaluated based on data from the Swedish Prescribed Drug Register, and Medication Possession Ratio (MPR), defined as the days' supply of medication during the period from the first dispensing till the last dispensing in the time period (3 and 5 years), divided by number of days. Adherence was defined as MPR >= 80%. Regression analyses were used to identify subgroups associated with adherence; age, type of endocrine treatment, additional adjuvant therapy, and hospital responsible for the follow-up (Eksjo, Jonkoping, and Varnamo).

Results: We identified 634 patients who were recommended adjuvant endocrine therapy and to be able to estimate adherence after 3 and 5 years, 488 patients were included in the analysis. After 3 years of treatment, 91.2% of the patients (95% confidence interval (0) 88.7-93.6; n = 445), were found to be adherent. The corresponding figure for the 271 patients who had completed 5 years of treatment was 91.5% (95% CI 88.2-94.8; n=248). No subgroups (age, endocrine therapy, radio/chemotherapy, or hospital) were significantly associated with adherence in the multiple logistic regression analysis.

Discussion: This study shows substantially higher adherence to adjuvant endocrine therapy than previously reported. Reasons for this could be differences in routines for therapy information and follow-up, but this needs to be further investigated.

Place, publisher, year, edition, pages
TAYLOR & FRANCIS LTD , 2018. Vol. 57, no 7, p. 935-940
National Category
Cancer and Oncology Nursing
Identifiers
URN: urn:nbn:se:uu:diva-362853DOI: 10.1080/0284186X.2018.1442932ISI: 000441790600008PubMedID: 29493327OAI: oai:DiVA.org:uu-362853DiVA, id: diva2:1255690
Funder
Futurum - Academy for Health and Care, Jönköping County Council, SwedenAvailable from: 2018-10-15 Created: 2018-10-15 Last updated: 2018-10-15Bibliographically approved

Open Access in DiVA

fulltext(1012 kB)91 downloads
File information
File name FULLTEXT02.pdfFile size 1012 kBChecksum SHA-512
1042e233e6c6d93aed273d6bf21fb468574a4cc3123633ce301bf69ed24c14d69c352e1a453a99658455fe17b0ddf10fe7bb610f13cd6f0cb338bba738070151
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records BETA

Lindman, Henrik

Search in DiVA

By author/editor
Lindman, Henrik
By organisation
Experimental and Clinical Oncology
In the same journal
Acta Oncologica
Cancer and OncologyNursing

Search outside of DiVA

GoogleGoogle Scholar
Total: 91 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 70 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf